Searched for
PHASE 3 VACCINATION
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- India’s next big challenge: From welfare delivery to human developmentThe National Family Health Survey 2023-24 reveals India's success in expanding welfare delivery and essential service access, reaching near...
- Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- In a medical breakthrough, first phase-3 dengue vaccine trial begins in IndiaIndia started its inaugural phase 3 clinical trial for the DengiAll dengue vaccine, developed by Panacea Biotec. The trial will include 10,...
- On first day, 1,000 people in 18-44 group inoculated in Mumbai"We have decided to vaccinate 200 people from the 18-44 age category today at each of all the five centres and we have fully achieved this ...
- Jharkhand fails to launch 3rd phase of vaccination drive for want of supply of additional vaccine stockThe state had placed demand for 50 lakh vaccine doses in advance to launch the vaccination campaign for 1.57 crore population in the 18-44 ...
- Over 2.45 crore register for Phase 3 of COVID-19 vaccinationWhile more than 1.37 crore people registered themselves on April 28, more than 1.04 crore registered by the end of April 29.
- Over 2.28 crore registrations on Co-Win portal for Phase-3 vaccination in 2 days"The country has administered more than 20 lakh vaccine doses till 8 pm today. Also, the total registrations on Co-Win portal for Phase-3 V...
- Zydus Cadila to release final vaccine data"The phase III trials for the vaccine are underway and it has been tested on 30,000 healthy adult volunteers in India,” the executive said....
- Phase-3 clinical trial of Covaxin commences in KolkataThe governor further said that the Centre's Ayushman Bharat scheme, which provides free healthcare services, has provided succour to many a...
- Bharat Biotech's COVID-19 vaccine "Covaxin" enters phase-3 trialsSpeaking virtually at a programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for ...
- India health authorities betting on AstraZeneca, Bharat Biotech vaccines“India will have to focus on the indigenous vaccines and the AstraZeneca-Oxford vaccine. These vaccines are being tested in the India popul...
- Bharat biotech's COVID-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trialThe vaccine 'Covaxin' is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (I...
- Bharat Biotech asked to submit complete phase 2 data of its COVID-19 vaccine before phase 3 trialAccording to officials, the Hyderabad-based vaccine maker applied to the Drugs Controller General of India (DCGI) on October 2, seeking its...
- Bharat Biotech to start phase III trials for its indigenously developed COVID-19 vaccine“We are planning to initiate a large phase 3 multicentre study to evaluate the efficacy and safety of the vaccine,” Bharat Biotech said in ...
- Scientists sceptical about Russia's Covid vaccine, cite lack of evidence for efficacyWhile the country hopes to start mass-producing the vaccine by October and plans to offer the first doses to essential workers, many in the...
Load More
